Introduction: The Shift Toward Long-term Survivorship Challenges
Heart transplantation (HT) remains the gold-standard intervention for end-stage heart failure, offering a dramatic extension of life for patients who would otherwise have few options. However, as surgical techniques, immunosuppression protocols, and post-operative monitoring have improved, the clinical focus has shifted. It is no longer enough to simply ensure immediate graft survival; clinicians must now manage the long-term, multi-systemic complications that arise from chronic immunosuppression, pre-existing comorbidities, and the physiological stress of the transplant itself.
A burgeoning area of concern is the Cardiovascular-Kidney-Metabolic (CKM) syndrome—a complex interplay of metabolic dysfunction, renal impairment, and cardiovascular disease. While the link between these factors is well-established in the general population, their specific burden and progression in the heart transplant population have been less clearly defined until now.
